Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
A Glaviano, ASC Foo, HY Lam, KCH Yap, W Jacot… - Molecular cancer, 2023 - Springer
Abstract The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal
transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell …
transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell …
Cancer stem cells—origins and biomarkers: perspectives for targeted personalized therapies
L Walcher, AK Kistenmacher, H Suo, R Kitte… - Frontiers in …, 2020 - frontiersin.org
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
Triple negative breast cancer (TNBC) is most aggressive subtype of breast cancers with high
probability of metastasis as well as lack of specific targets and targeted therapeutics. TNBC …
probability of metastasis as well as lack of specific targets and targeted therapeutics. TNBC …
Targeting mTOR for cancer therapy
H Hua, Q Kong, H Zhang, J Wang, T Luo… - Journal of hematology & …, 2019 - Springer
Mechanistic target of rapamycin (mTOR) is a protein kinase regulating cell growth, survival,
metabolism, and immunity. mTOR is usually assembled into several complexes such as …
metabolism, and immunity. mTOR is usually assembled into several complexes such as …
Targeting Notch in oncology: the path forward
Notch signalling is involved in many aspects of cancer biology, including angiogenesis,
tumour immunity and the maintenance of cancer stem-like cells. In addition, Notch can …
tumour immunity and the maintenance of cancer stem-like cells. In addition, Notch can …
Insights into new mechanisms and models of cancer stem cell multidrug resistance
Y Garcia-Mayea, C Mir, F Masson, R Paciucci… - Seminars in cancer …, 2020 - Elsevier
The acquisition of genetic alterations, clonal evolution, and the tumor microenvironment
promote cancer progression, metastasis and therapy resistance. These events correspond …
promote cancer progression, metastasis and therapy resistance. These events correspond …
Recent advances with precision medicine treatment for breast cancer including triple-negative sub-type
Simple Summary The progress of next-generation sequencing technologies has raised
huge expectations for precision-medicine therapy approaches in breast cancer and triple …
huge expectations for precision-medicine therapy approaches in breast cancer and triple …
[HTML][HTML] Recent therapeutic trends and promising targets in triple negative breast cancer
SY Hwang, S Park, Y Kwon - Pharmacology & therapeutics, 2019 - Elsevier
Breast cancer accounts for 25% of all types of cancer in women, and triple negative breast
cancer (TNBC) comprises around 15~ 20% of breast cancers. Conventional chemotherapy …
cancer (TNBC) comprises around 15~ 20% of breast cancers. Conventional chemotherapy …
Cancer stem cell signaling pathways
WH Matsui - Medicine, 2016 - journals.lww.com
Tissue development and homeostasis are governed by the actions of stem cells. Multipotent
cells are capable of self-renewal during the course of one's lifetime. The accurate and …
cells are capable of self-renewal during the course of one's lifetime. The accurate and …
Notch signalling in breast development and cancer
A Edwards, K Brennan - Frontiers in Cell and Developmental Biology, 2021 - frontiersin.org
The Notch signalling pathway is a highly conserved developmental signalling pathway, with
vital roles in determining cell fate during embryonic development and tissue homeostasis …
vital roles in determining cell fate during embryonic development and tissue homeostasis …